HLS Therapeutics Inc's total assets for Q4 2025 were $137.28M, a decrease of -2.10% from the previous quarter. TSE:HLS total liabilities were $75.72M for the fiscal quarter, a -3.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.